1,2-dimethylhydrazine multiple interactions ISO RGD:1316259 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPHA2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of EPHA2 mRNA CTD PMID:20551477 17alpha-ethynylestradiol affects expression ISO RGD:1316259 6480464 Ethinyl Estradiol affects the expression of EPHA2 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1316259 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPHA2 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1316259 6480464 Estradiol results in increased expression of EPHA2 mRNA CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1316259 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EPHA2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EPHA2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPHA2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1316258 6480464 Tetrachlorodibenzodioxin results in increased expression of EPHA2 mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1316258 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPHA2 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1316259 6480464 Tetrachlorodibenzodioxin results in decreased expression of EPHA2 mRNA CTD PMID:19933214 , PMID:21889950 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1316259 6480464 Tetrachlorodibenzodioxin affects the expression of EPHA2 mRNA CTD PMID:20702594 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:1316259 6480464 2 more ... CTD PMID:20702594 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1316259 6480464 tetrabromobisphenol A results in increased expression of EPHA2 mRNA CTD PMID:25172293 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of EPHA2 mRNA CTD PMID:30723492 4,4'-sulfonyldiphenol decreases expression ISO RGD:1316259 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of EPHA2 mRNA CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:1316259 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of EPHA2 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO RGD:1316259 6480464 Fenretinide results in increased expression of EPHA2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects methylation ISO RGD:1316258 6480464 Decitabine affects the methylation of EPHA2 gene CTD PMID:17630775 5-fluorouracil multiple interactions ISO RGD:1316258 6480464 TP53 protein affects the reaction [Fluorouracil results in increased expression of EPHA2 mRNA] CTD PMID:15016801 aflatoxin B1 affects expression ISO RGD:1316258 6480464 Aflatoxin B1 affects the expression of EPHA2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1316258 6480464 Aflatoxin B1 results in increased methylation of EPHA2 intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:1316258 6480464 Aflatoxin B1 results in increased expression of EPHA2 mRNA CTD PMID:21632981 more ... all-trans-retinoic acid increases expression ISO RGD:1316259 6480464 Tretinoin results in increased expression of EPHA2 mRNA CTD PMID:16604517 all-trans-retinoic acid multiple interactions ISO RGD:1316259 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of EPHA2 mRNA CTD PMID:30951980 antimonite multiple interactions ISO RGD:1316258 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein CTD PMID:32076005 aristolochic acid A increases expression ISO RGD:1316258 6480464 aristolochic acid I results in increased expression of EPHA2 mRNA, aristolochic acid I results in increased expression of EPHA2 protein CTD PMID:33212167 arsane multiple interactions ISO RGD:1316258 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EPHA2 mRNA CTD PMID:32525701 arsane affects methylation ISO RGD:1316258 6480464 Arsenic affects the methylation of EPHA2 gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:1316258 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EPHA2 mRNA CTD PMID:32525701 arsenic atom affects methylation ISO RGD:1316258 6480464 Arsenic affects the methylation of EPHA2 gene CTD PMID:25304211 arsenite(3-) multiple interactions ISO RGD:1316258 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA2 protein CTD PMID:32076005 atrazine increases expression ISO RGD:1316258 6480464 Atrazine results in increased expression of EPHA2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1316259 6480464 Benzo(a)pyrene results in decreased expression of EPHA2 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1316258 6480464 Benzo(a)pyrene results in increased expression of EPHA2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1316259 6480464 Benzo(a)pyrene results in increased expression of EPHA2 mRNA CTD PMID:21569818 , PMID:22610609 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1316258 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene increases expression ISO RGD:1316259 6480464 benzo(b)fluoranthene results in increased expression of EPHA2 mRNA CTD PMID:26377693 bexarotene decreases expression ISO RGD:1316258 6480464 bexarotene results in decreased expression of EPHA2 mRNA CTD PMID:17178900 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of EPHA2 mRNA CTD PMID:15651846 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EPHA2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1316259 6480464 bisphenol A results in increased expression of EPHA2 mRNA CTD PMID:32156529 bisphenol A decreases expression ISO RGD:1316258 6480464 bisphenol A results in decreased expression of EPHA2 mRNA CTD PMID:29275510 bisphenol A decreases methylation ISO RGD:1316259 6480464 bisphenol A results in decreased methylation of EPHA2 promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:1316259 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of EPHA2 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1316258 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of EPHA2 mRNA CTD PMID:29432896 butanal increases expression ISO RGD:1316258 6480464 butyraldehyde results in increased expression of EPHA2 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of EPHA2 mRNA CTD PMID:19010381 cadmium dichloride increases expression ISO RGD:1316258 6480464 Cadmium Chloride results in increased expression of EPHA2 mRNA CTD PMID:26472689 caffeine affects phosphorylation ISO RGD:1316258 6480464 Caffeine affects the phosphorylation of EPHA2 protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:1316258 6480464 Carbamazepine affects the expression of EPHA2 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1316259 6480464 Nanotubes, Carbon affects the expression of EPHA2 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:1316259 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 cholanic acid multiple interactions ISO RGD:1316258 6480464 cholanic acid binds to and results in decreased activity of EPHA2 protein, cholanic acid inhibits the reaction [EFNA1 protein binds to and results in increased phosphorylation of and results in increased activity of EPHA2 protein] CTD PMID:22529030 cocaine affects expression EXP 6480464 Cocaine affects the expression of EPHA2 mRNA CTD PMID:15691709 copper(II) sulfate increases expression ISO RGD:1316258 6480464 Copper Sulfate results in increased expression of EPHA2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1316258 6480464 Asbestos, Crocidolite results in increased expression of EPHA2 mRNA CTD PMID:18687144 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of EPHA2 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:1316258 6480464 Cyclosporine results in increased expression of EPHA2 mRNA CTD PMID:20106945 , PMID:25562108 cyproconazole decreases expression ISO RGD:1316259 6480464 cyproconazole results in decreased expression of EPHA2 mRNA CTD PMID:22045034 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of EPHA2 mRNA CTD PMID:23640034 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of EPHA2 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1316259 6480464 Dibutyl Phthalate results in increased expression of EPHA2 mRNA CTD PMID:17361019 , PMID:21266533 dioxygen multiple interactions ISO RGD:1316259 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EPHA2 mRNA CTD PMID:30529165 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate multiple interactions ISO RGD:1316258 6480464 [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein CTD PMID:32076005 dorsomorphin multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxazosin multiple interactions ISO RGD:1316259 6480464 [Doxazosin results in increased phosphorylation of and results in increased activity of EPHA2 protein] which results in increased phosphorylation of and results in increased activity of PTPN11 protein more ... CTD PMID:22845314 doxorubicin increases expression ISO RGD:1316258 6480464 Doxorubicin results in increased expression of EPHA2 mRNA CTD PMID:16900372 , PMID:29803840 entinostat increases expression ISO RGD:1316258 6480464 entinostat results in increased expression of EPHA2 mRNA CTD PMID:32870474 epoxiconazole increases expression ISO RGD:1316259 6480464 epoxiconazole results in increased expression of EPHA2 mRNA CTD PMID:35436446 fenamidone increases expression ISO RGD:1316259 6480464 fenamidone results in increased expression of EPHA2 mRNA CTD PMID:27029645 fluoranthene multiple interactions ISO RGD:1316259 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of EPHA2 mRNA CTD PMID:28329830 folic acid multiple interactions ISO RGD:1316259 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EPHA2 mRNA CTD PMID:22206623 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of EPHA2 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO RGD:1316258 6480464 Hydrogen Peroxide affects the expression of EPHA2 mRNA CTD PMID:20044591 hydrogen peroxide multiple interactions ISO RGD:1316259 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of EPHA2 mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:1316258 6480464 Ivermectin results in decreased expression of EPHA2 protein CTD PMID:32959892 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of EPHA2 mRNA CTD PMID:11578147 leflunomide increases expression ISO RGD:1316258 6480464 leflunomide results in increased expression of EPHA2 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1316258 6480464 licochalcone B results in increased expression of EPHA2 mRNA CTD PMID:33647349 lithocholic acid multiple interactions ISO RGD:1316258 6480464 Lithocholic Acid analog binds to and results in decreased phosphorylation of and results in decreased activity of EPHA2 protein more ... CTD PMID:21479221 more ... lithocholic acid increases expression ISO RGD:1316259 6480464 Lithocholic Acid results in increased expression of EPHA2 protein CTD PMID:22845314 lithocholic acid multiple interactions ISO RGD:1316259 6480464 Lithocholic Acid inhibits the reaction [Doxazosin results in increased phosphorylation of and results in increased activity of EPHA2 protein] CTD PMID:22845314 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of EPHA2 mRNA CTD PMID:28801915 mercury dibromide multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA CTD PMID:27188386 metacetamol decreases expression ISO RGD:1316259 6480464 3-hydroxyacetanilide results in decreased expression of EPHA2 mRNA CTD PMID:18544908 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of EPHA2 mRNA CTD PMID:30467583 methotrexate affects expression ISO RGD:1316259 6480464 Methotrexate affects the expression of EPHA2 mRNA CTD PMID:18502557 methylmercury chloride affects expression ISO RGD:1316259 6480464 methylmercuric chloride affects the expression of EPHA2 mRNA CTD PMID:21613230 methylmercury chloride multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:1316258 6480464 methylmercuric chloride results in increased expression of EPHA2 mRNA CTD PMID:23179753 more ... mitomycin C decreases expression ISO RGD:1316258 6480464 Mitomycin results in decreased expression of EPHA2 mRNA CTD PMID:12760830 N-methyl-4-phenylpyridinium increases expression ISO RGD:1316258 6480464 1-Methyl-4-phenylpyridinium results in increased expression of EPHA2 mRNA CTD PMID:24810058 , PMID:32870474 N-Nitrosopyrrolidine increases expression ISO RGD:1316258 6480464 N-Nitrosopyrrolidine results in increased expression of EPHA2 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1316258 6480464 Nickel results in increased expression of EPHA2 mRNA CTD PMID:25583101 nickel subsulfide decreases expression ISO RGD:1316258 6480464 nickel subsulfide results in decreased expression of EPHA2 mRNA CTD PMID:12760830 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of EPHA2 mRNA CTD PMID:23665939 ozone multiple interactions ISO RGD:1316259 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EPHA2 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA CTD PMID:27188386 paracetamol affects expression ISO RGD:1316259 6480464 Acetaminophen affects the expression of EPHA2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of EPHA2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1316258 6480464 Acetaminophen results in increased expression of EPHA2 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1316259 6480464 Acetaminophen results in increased expression of EPHA2 mRNA CTD PMID:18544908 paraquat increases expression EXP 6480464 Paraquat results in increased expression of EPHA2 mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:1316258 6480464 pentanal results in increased expression of EPHA2 mRNA CTD PMID:26079696 perfluorononanoic acid increases expression ISO RGD:1316258 6480464 perfluoro-n-nonanoic acid results in increased expression of EPHA2 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression ISO RGD:1316258 6480464 perfluorooctanoic acid results in increased expression of EPHA2 protein CTD PMID:26879310 phenylmercury acetate increases expression ISO RGD:1316258 6480464 Phenylmercuric Acetate results in increased expression of EPHA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EPHA2 mRNA CTD PMID:27188386 phosgene affects expression ISO RGD:1316259 6480464 Phosgene affects the expression of EPHA2 mRNA CTD PMID:16300373 pirinixic acid multiple interactions ISO RGD:1316259 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of EPHA2 mRNA] CTD PMID:20059764 pirinixic acid increases expression ISO RGD:1316259 6480464 pirinixic acid results in increased expression of EPHA2 mRNA CTD PMID:18445702 , PMID:20059764 ponatinib decreases activity ISO RGD:1316258 6480464 ponatinib analog results in decreased activity of EPHA2 protein, ponatinib results in decreased activity of EPHA2 protein CTD PMID:19878872 , PMID:21561767 propanal increases expression ISO RGD:1316258 6480464 propionaldehyde results in increased expression of EPHA2 mRNA CTD PMID:26079696 prothioconazole increases expression ISO RGD:1316258 6480464 prothioconazole results in increased expression of EPHA2 mRNA CTD PMID:35048155 quercetin increases expression ISO RGD:1316258 6480464 Quercetin results in increased expression of EPHA2 mRNA CTD PMID:21632981 quercetin decreases phosphorylation ISO RGD:1316258 6480464 Quercetin results in decreased phosphorylation of EPHA2 protein CTD PMID:35688186 rotenone increases expression ISO RGD:1316258 6480464 Rotenone results in increased expression of EPHA2 mRNA CTD PMID:32870474 SB 431542 multiple interactions ISO RGD:1316258 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine increases expression ISO RGD:1316259 6480464 senecionine results in increased expression of EPHA2 protein CTD PMID:35357534 silicon dioxide increases expression ISO RGD:1316258 6480464 Silicon Dioxide analog results in increased expression of EPHA2 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:1316259 6480464 Silicon Dioxide results in decreased expression of EPHA2 mRNA CTD PMID:29203145 silicon dioxide increases expression ISO RGD:1316259 6480464 Silicon Dioxide results in increased expression of EPHA2 mRNA CTD PMID:19073995 , PMID:33720480 silver atom increases expression ISO RGD:1316258 6480464 Silver results in increased expression of EPHA2 mRNA CTD PMID:26014281 more ... silver(0) increases expression ISO RGD:1316258 6480464 Silver results in increased expression of EPHA2 mRNA CTD PMID:26014281 more ... sodium arsenate multiple interactions ISO RGD:1316258 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of EPHA2 mRNA CTD PMID:32525701 sodium arsenite increases expression ISO RGD:1316258 6480464 sodium arsenite results in increased expression of EPHA2 mRNA CTD PMID:12760830 , PMID:29301061 sodium arsenite multiple interactions ISO RGD:1316258 6480464 [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of EPHA2 protein CTD PMID:32076005 sodium dichromate decreases expression ISO RGD:1316258 6480464 sodium bichromate results in decreased expression of EPHA2 mRNA CTD PMID:12760830 Soman increases expression EXP 6480464 Soman results in increased expression of EPHA2 mRNA CTD PMID:19281266 temozolomide increases expression ISO RGD:1316258 6480464 Temozolomide results in increased expression of EPHA2 mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1316258 6480464 Testosterone results in decreased expression of EPHA2 mRNA CTD PMID:33359661 Testosterone propionate decreases expression ISO RGD:1316259 6480464 Testosterone Propionate results in decreased expression of EPHA2 mRNA CTD PMID:15601916 tetrachloromethane increases expression ISO RGD:1316259 6480464 Carbon Tetrachloride results in increased expression of EPHA2 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EPHA2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1316259 6480464 titanium dioxide results in increased expression of EPHA2 mRNA CTD PMID:27760801 triadimefon decreases activity ISO RGD:1316258 6480464 triadimefon results in decreased activity of EPHA2 protein CTD PMID:21251949 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of EPHA2 mRNA CTD PMID:33387578 trimellitic anhydride decreases expression ISO RGD:1316259 6480464 trimellitic anhydride results in decreased expression of EPHA2 mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of EPHA2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1316259 6480464 triptonide results in increased expression of EPHA2 mRNA CTD PMID:33045310 trovafloxacin increases expression ISO RGD:1316259 6480464 trovafloxacin results in increased expression of EPHA2 mRNA CTD PMID:35537566 valproic acid increases expression ISO RGD:1316259 6480464 Valproic Acid results in increased expression of EPHA2 mRNA CTD PMID:19136453 valproic acid affects expression ISO RGD:1316259 6480464 Valproic Acid affects the expression of EPHA2 mRNA CTD PMID:26072468 valproic acid affects expression ISO RGD:1316258 6480464 Valproic Acid affects the expression of EPHA2 mRNA CTD PMID:25979313 , PMID:26072468 valproic acid decreases expression ISO RGD:1316259 6480464 Valproic Acid results in decreased expression of EPHA2 mRNA CTD PMID:22045034 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of EPHA2 mRNA CTD PMID:23034163 zinc atom multiple interactions ISO RGD:1316258 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EPHA2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1316258 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of EPHA2 mRNA CTD PMID:18593933